Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-014684
Filing Date
2021-02-26
Accepted
2021-02-26 16:05:16
Documents
1
Period of Report
2020-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8209
  Complete submission text file 0001209191-21-014684.txt   9913
Mailing Address 19 MORRIS AVENUE BROOKLYN NAVY YARD, BUILDING 128 BROOKLYN NY 11205
Business Address 19 MORRIS AVENUE BROOKLYN NAVY YARD, BUILDING 128 BROOKLYN NY 11205 (516) 962-3186
Cambrian BioPharma Inc (Reporting) CIK: 0001797409 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 21688690

Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations